Boston (PRWEB) September 16, 2015
David J. Dykeman, patent attorney, co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, and co-chair of the firm’s Intellectual Property (IP) Group in Boston, will present at the 2015 Shenzhen International Biotechnology Summit and Biological/Health Industry Expo, Sept. 23 - 25, 2015, in Shenzhen, China.
On Sept. 23, Dykeman will present at two sessions during the Shenzhen International Biotechnology Summit. He will be a featured presenter on the topic “New Technologies and Trends in Cell Therapy.” In addition, Dykeman will serve as a panelist for the program, “Policies and Regulations for Biologics, Healthcare Technologies and Medical Devices.”
A registered patent attorney with nearly 20 years of experience in patents, intellectual property, and licensing, Dykeman focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in life sciences, medical devices, biotechnology, and healthcare IT. Dykeman is the founding co-chair of the American Bar Association’s (ABA) Medical Devices Committee and serves on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine.
An author of over 45 articles and a speaker at over 40 conferences on medical devices and life sciences intellectual property, Dykeman was honored as a “Life Science Star” by LMG Life Sciences, and was named one of the Top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.
The 2015 Shenzhen International Biotechnology Summit and Biological/Health Industry Expo will present attendees with a comprehensive discussion of global biotechnology development and will highlight the commercialization of biotech research findings. Over 40,000 industry leaders and investors from Asia, America, Europe, and Oceania, are expected to attend this year’s summit.
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Boston Office
Established in 1999, Greenberg Traurig’s Boston office is home to more than 65 attorneys practicing in the areas of corporate, emerging technology, energy, governmental affairs, healthcare, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate and securities. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1800 attorneys serving clients from 37 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is among the 2015 BTI Brand Elite and among the most “Tech Savvy.” It was on the 2013-2015 BTI Client Service 30 listings of firms “most recognized by clients for providing excellent client service,” and one of the 2014 BTI Client Relationship Scorecard “Power Elite,” based on the nature and strength of its client relationships. More information at: http://www.gtlaw.com.